A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma
- PMID: 7016157
- PMCID: PMC2010639
- DOI: 10.1038/bjc.1981.64
A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma
Abstract
The results are reported of a small clinical trial carried out to assess the potential value of the hypoxic cell radiosensitizer misonidazole in the radiation treatment of Grade 3 and 4 supratentorial astrocytomas. A total of 55 patients were randomly allocated to one of 3 treatment groups. No significant differences were seen between the median survivals of patients in the 2 control radiation groups and that of the third group in which oral misonidazole at a dose of 3 g/m2 preceded each of 4 weekly radiation doses. Possible reasons why no improvement was seen are discussed in detail.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
